Actavis

NCT03287791

Phase 3, Completed, 2016, 924 people, 19 Sept 2017, clinicaltrials.gov

NCT01966003

Collaborator, Phase 3, Completed, 2013, 642 people, 21 Oct 2013, clinicaltrials.gov

NCT01901146

Collaborator, Phase 3, Completed, 2013, 725 people, 17 Jul 2013, clinicaltrials.gov

NCT00865631

Phase 1, Completed, 1999, 18 people, 19 Mar 2009, clinicaltrials.gov

NCT00865423

Phase 1, Completed, 2001, 28 people, 19 Mar 2009, clinicaltrials.gov

NCT00865059

Phase 1, Completed, 2001, 24 people, 19 Mar 2009, clinicaltrials.gov

NCT00864760

Phase 1, Completed, 1999, 30 people, 19 Mar 2009, clinicaltrials.gov

NCT00865462

Phase 1, Completed, 2004, 30 people, 19 Mar 2009, clinicaltrials.gov

NCT00865410

Phase 1, Completed, 2004, 26 people, 19 Mar 2009, clinicaltrials.gov

NCT00865371

Phase 1, Completed, 2004, 26 people, 19 Mar 2009, clinicaltrials.gov

NCT00865111

Phase 1, Completed, 2006, 26 people, 19 Mar 2009, clinicaltrials.gov

NCT00865852

Phase 1, Completed, 2003, 40 people, 19 Mar 2009, clinicaltrials.gov

NCT00865839

Phase 1, Completed, 2002, 32 people, 19 Mar 2009, clinicaltrials.gov

NCT00865748

Phase 1, Completed, 2004, 40 people, 19 Mar 2009, clinicaltrials.gov

NCT00865436

Phase 1, Completed, 2004, 36 people, 19 Mar 2009, clinicaltrials.gov

NCT00865241

Phase 1, Completed, 2002, 36 people, 19 Mar 2009, clinicaltrials.gov

NCT00865072

Phase 1, Completed, 2003, 40 people, 19 Mar 2009, clinicaltrials.gov

NCT00864734

Phase 1, Completed, 2002, 24 people, 19 Mar 2009, clinicaltrials.gov

NCT00864669

Phase 1, Completed, 2002, 32 people, 19 Mar 2009, clinicaltrials.gov

NCT00864305

Phase 1, Completed, 1997, 18 people, 18 Mar 2009, clinicaltrials.gov